留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

促进自体冻存卵巢组织移植存活的方法研究进展

屈凌寒 余州 宋保强

屈凌寒, 余州, 宋保强. 促进自体冻存卵巢组织移植存活的方法研究进展[J]. 器官移植, 2021, 12(1): 43-50. doi: 10.3969/j.issn.1674-7445.2021.01.007
引用本文: 屈凌寒, 余州, 宋保强. 促进自体冻存卵巢组织移植存活的方法研究进展[J]. 器官移植, 2021, 12(1): 43-50. doi: 10.3969/j.issn.1674-7445.2021.01.007
Qu Linghan, Yu Zhou, Song Baoqiang. Research progress of methods to promote the survival of cryopreserved ovarian tissue auto-transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 43-50. doi: 10.3969/j.issn.1674-7445.2021.01.007
Citation: Qu Linghan, Yu Zhou, Song Baoqiang. Research progress of methods to promote the survival of cryopreserved ovarian tissue auto-transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 43-50. doi: 10.3969/j.issn.1674-7445.2021.01.007

促进自体冻存卵巢组织移植存活的方法研究进展

doi: 10.3969/j.issn.1674-7445.2021.01.007
基金项目: 

陕西省重点研发计划 2020SF-179

西京医院学科助推计划 XJZT18Z05

详细信息
    作者简介:

    屈凌寒,男,1988年生,学士,研究方向为卵巢组织移植,Email:2427927607@qq.com

    通讯作者:

    余州,男,1982年生,博士,助理研究员,研究方向为异体复合组织移植,Email:yz20080512@163.com

    宋保强,男,1970年生,博士,教授、主任医师,研究方向为异体复合组织移植,Email:songbq1@163.com

  • 中图分类号: R617, R713.6

Research progress of methods to promote the survival of cryopreserved ovarian tissue auto-transplantation

More Information
  • 摘要: 随着癌症治疗技术的发展,癌症患者的生存率显著提高。但化学药物治疗(化疗)和放射治疗(放疗)可能导致年轻女性癌症患者发生卵巢早衰和不孕,而自体冻存卵巢组织移植是这类患者保存生育能力的有效方法。目前,该技术最大的挑战是移植后卵泡大量丢失。本文综述了自体冻存卵巢组织移植存活的影响因素及改善方法。

     

  • [1] SIEGEL RL, MILLER KD, JEMAL A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1):7-30. DOI: 10. 3322/caac.21590.
    [2] DONNEZ J, DOLMANS MM, DEMYLLE D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue[J]. Lancet, 2004, 364(9443):1405-1410. DOI: 10.1016/S0140-6736(04)17222-X.
    [3] SILBER S, PINEDA J, LENAHAN K, et al. Fresh and cryopreserved ovary transplantation and resting follicle recruitment[J]. Reprod Biomed Online, 2015, 30(6):643-650. DOI: 10.1016/j.rbmo.2015.02.010.
    [4] GELLERT SE, PORS SE, KRISTENSEN SG, et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort[J]. J Assist Reprod Genet, 2018, 35(4):561-570. DOI: 10.1007/s10815-018-1144-2.
    [5] RODRIGUEZ-WALLBERG KA, TANBO T, TINKANEN H, et al. Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries - compilation of 20 years of multicenter experience[J]. Acta Obstet Gynecol Scand, 2016, 95(9):1015-1026. DOI: 10.1111/aogs.12934.
    [6] RONESS H, MEIROW D. Fertility preservation: follicle reserve loss in ovarian tissue transplantation[J]. Reproduction, 2019, 158(5):F35-F44. DOI: 10.1530/REP-19-0097.
    [7] RIVAS LEONEL EC, LUCCI CM, AMORIM CA. Cryopreservation of human ovarian tissue: a review[J]. Transfus Med Hemother, 2019, 46(3):173-181. DOI: 10.1159/000499054.
    [8] SHI Q, XIE Y, WANG Y, et al. Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and Meta-analysis[J]. Sci Rep, 2017, 7(1):8538. DOI: 10.1038/s41598-017-09005-7.
    [9] BASTINGS L, WESTPHAL JR, BEERENDONK CC, et al. Clinically applied procedures for human ovarian tissue cryopreservation result in different levels of efficacy and efficiency[J]. J Assist Reprod Genet, 2016, 33(12):1605-1614. DOI: 10.1007/s10815-016-0816-z.
    [10] DONNEZ J, DOLMANS MM. Fertility preservation in women[J]. N Engl J Med, 2017, 377(17):1657-1665. DOI: 10.1056/NEJMra1614676.
    [11] VON WOLFF M, GERMEYER A, LIEBENTHRON J, et al. Practical recommendations for fertility preservation in women by the FertiPROTEKT network. partⅡ: fertility preservation techniques[J]. Arch Gynecol Obstet, 2018, 297(1):257-267. DOI: 10.1007/s00404-017-4595-2.
    [12] DONNEZ J, DOLMANS MM. Cryopreservation and transplantation of ovarian tissue[J]. Clin Obstet Gynecol, 2010, 53(4):787-796. DOI: 10.1097/GRF. 0b013e3181f97a55.
    [13] YOUM HW, LEE JR, LEE J, et al. Transplantation of mouse ovarian tissue: comparison of the transplantation sites[J]. Theriogenology, 2015, 83(5):854-861. DOI: 10.1016/j.theriogenology.2014.11.026.
    [14] MEIROW D, RA'ANANI H, SHAPIRA M, et al. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria[J]. Fertil Steril, 2016, 106(2):467-474. DOI: 10.1016/j.fertnstert.2016.04.031.
    [15] DONNEZ J, DOLMANS MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice[J]. J Assist Reprod Genet, 2015, 32(8):1167-1170. DOI: 10.1007/s10815-015-0544-9.
    [16] HERRAIZ S, MONZÓ S, GÓMEZ-GIMÉNEZ B, et al. Optimizing ovarian tissue quality before cryopreservation: comparing outcomes of three decortication methods on stromal and follicular viability[J]. Fertil Steril, 2020, 113(3):609-617. DOI: 10.1016/j.fertnstert.2019. 10.030.
    [17] MARTINEZ-MADRID B, DOLMANS MM, VAN LANGENDONCKT A, et al. Freeze-thawing intact human ovary with its vascular pedicle with a passive cooling device[J]. Fertil Steril, 2004, 82(5):1390-1394. DOI: 10.1016/j.fertnstert.2004.06.036.
    [18] CAMPBELL BK, HERNANDEZ-MEDRANO J, ONIONS V, et al. Restoration of ovarian function and natural fertility following the cryopreservation and autotransplantation of whole adult sheep ovaries[J]. Hum Reprod, 2014, 29(8):1749-1763. DOI: 10.1093/humrep/deu144.
    [19] TANAKA A, NAKAMURA H, TABATA Y, et al. Effect of sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogels on frozen-thawed human ovarian tissue in a xenograft model[J]. J Obstet Gynaecol Res, 2018, 44(10):1947-1955. DOI: 10.1111/jog.13726.
    [20] TAKAE S, SUZUKI N. Current state and future possibilities of ovarian tissue transplantation[J]. Reprod Med Biol, 2019, 18(3):217-224. DOI: 10.1002/rmb2.12268.
    [21] SUZUKI H, ISHIJIMA T, MARUYAMA S, et al. Beneficial effect of desialylated erythropoietin administration on the frozen-thawed canine ovarian xenotransplantation[J]. J Assist Reprod Genet, 2008, 25(11/12):571-575. DOI: 10.1007/s10815-008-9271-9.
    [22] MA WZ, ZHENG XM, HEI CC, et al. Optimal FSH usage in revascularization of allotransplanted ovarian tissue in mice[J]. J Ovarian Res, 2017, 10(1):5. DOI: 10.1186/s13048-016-0299-7.
    [23] ZHENG X, CHEN J, YANG Y, et al. Exogenous luteinizing hormone promotes ovarian survival and function during cryopreservation and transplantation[J]. Biochem Biophys Res Commun, 2020, 526(2):424-430. DOI: 10.1016/j.bbrc.2020.03.014.
    [24] WEISSMAN A, GOTLIEB L, COLGAN T, et al. Preliminary experience with subcutaneous human ovarian cortex transplantation in the NOD-SCID mouse[J]. Biol Reprod, 1999, 60(6):1462-1467. DOI: 10.1095/biolreprod60.6.1462.
    [25] WATERHOUSE T, COX SL, SNOW M, et al. Offspring produced from heterotopic ovarian allografts in male and female recipient mice[J]. Reproduction, 2004, 127(6):689-694. DOI: 10.1530/rep.1.00081.
    [26] GAVISH Z, SPECTOR I, PEER G, et al. Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation[J]. J Assist Reprod Genet, 2018, 35(1):61-69. DOI: 10.1007/s10815-017-1079-z.
    [27] MAN L, PARK L, BODINE R, et al. Engineered endothelium provides angiogenic and paracrine stimulus to grafted human ovarian tissue[J]. Sci Rep, 2017, 7(1):8203. DOI: 10.1038/s41598-017-08491-z.
    [28] DURLINGER AL, KRAMER P, KARELS B, et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary[J]. Endocrinology, 1999, 140(12):5789-5796. DOI: 10.1210/endo.140.12.7204.
    [29] CAMPBELL BK, CLINTON M, WEBB R. The role of anti-Müllerian hormone (AMH) during follicle development in a monovulatory species (sheep)[J]. Endocrinology, 2012, 153(9):4533-4543. DOI: 10.1210/en.2012-1158.
    [30] KONG HS, KIM SK, LEE J, et al. Effect of exogenous anti-Müllerian hormone treatment on cryopreserved and transplanted mouse ovaries[J]. Reprod Sci, 2016, 23(1):51-60. DOI: 10.1177/1933719115594021.
    [31] YANG Y, CHEUNG HH, LAW WN, et al. New insights into the role of autophagy in ovarian cryopreservation by vitrification[J]. Biol Reprod, 2016, 94(6):137. DOI: 10.1095/biolreprod.115.136374.
    [32] WANG HX, LU XL, HUANG WJ, et al. Pyroptosis is involved in cryopreservation and auto-transplantation of mouse ovarian tissues and pyroptosis inhibition improves ovarian graft function[J]. Res Vet Sci, 2019, 124:52-56. DOI: 10.1016/j.rvsc.2019.02.004.
    [33] JIN X, HAN CS, YU FQ, et al. Anti-apoptotic action of stem cell factor on oocytes in primordial follicles and its signal transduction[J]. Mol Reprod Dev, 2005, 70(1):82-90. DOI: 10.1002/mrd.20142.
    [34] LIU H, LUO LL, QIAN YS, et al. Foxo3a is involved in the apoptosis of naked oocytes and oocytes of primordial follicles from neonatal rat ovaries[J]. Biochem Biophys Res Commun, 2009, 381(4):722-727. DOI: 10.1016/j.bbrc.2009.02.138.
    [35] EZZATI MM, BAKER MD, SAATCIOGLU HD, et al. Regulation of Foxo3 subcellular localization by Kit ligand in the neonatal mouse ovary[J]. J Assist Reprod Genet, 2015, 32(12):1741-1747. DOI: 10.1007/s10815-015-0589-9.
    [36] LI F, TURAN V, LIERMAN S, et al. Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death[J]. Hum Reprod, 2014, 29(1):107-113. DOI: 10.1093/humrep/det391.
    [37] LADANYI C, MOR A, CHRISTIANSON MS, et al. Recent advances in the field of ovarian tissue cryopreservation and opportunities for research[J].J Assist Reprod Genet, 2017, 34(6):709-722. DOI: 10.1007/s10815-017-0899-1.
    [38] KOLUSARI A, OKYAY AG, KOÇKAYA EA. The effect of erythropoietin in preventing ischemia-reperfusion injury in ovarian tissue transplantation[J]. Reprod Sci, 2018, 25(3):406-413. DOI: 10.1177/1933719117715127.
    [39] DING Y, SHAO JL, LI JW, et al. Successful fertility following optimized perfusion and cryopreservation of whole ovary and allotransplantation in a premature ovarian insufficiency rat model[J]. J Ovarian Res, 2018, 11(1):35. DOI: 10.1186/s13048-018-0401-4.
    [40] ZHANG S, YAO H, LIU Y, et al. Hypothermic machine perfusion after static cold storage improves ovarian function in rat ovarian tissue transplantation[J]. J Assist Reprod Genet, 2020, 37(7):1745-1753. DOI: 10.1007/s10815-020-01797-4.
    [41] SABER M, EIMANI H, SOLEIMANI MEHRANJANI M, et al. The effect of verapamil on ischaemia/reperfusion injury in mouse ovarian tissue transplantation[J]. Biomed Pharmacother, 2018, 108:1313-1319. DOI: 10.1016/j.biopha.2018.09.130.
    [42] SONG L, SUN Z, KIM DS, et al. Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function[J]. Stem Cell Res Ther, 2017, 8(1):192. DOI: 10.1186/s13287-017-0627-x.
    [43] MANAVELLA DD, CACCIOTTOLA L, DESMET CM, et al. Adipose tissue-derived stem cells in a fibrin implant enhance neovascularization in a peritoneal grafting site: a potential way to improve ovarian tissue transplantation[J]. Hum Reprod, 2018, 33(2):270-279. DOI: 10.1093/humrep/dex374.
    [44] MANAVELLA DD, CACCIOTTOLA L, POMMÉ S, et al. Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen-thawed human ovarian tissue[J]. Hum Reprod, 2018, 33(6):1107-1116. DOI: 10.1093/humrep/dey080.
    [45] DOLMANS MM, CACCIOTTOLA L, AMORIM CA, et al. Translational research aiming to improve survival of ovarian tissue transplants using adipose tissue-derived stem cells[J]. Acta Obstet Gynecol Scand, 2019, 98(5):665-671. DOI: 10.1111/aogs.13610.
    [46] CACCIOTTOLA L, NGUYEN TYT, CHITI MC, et al. Long-term advantages of ovarian reserve maintenance and follicle development using adipose tissue-derived stem cells in ovarian tissue transplantation[J]. J Clin Med, 2020, 9(9):2980. DOI: 10.3390/jcm9092980.
  • 加载中
计量
  • 文章访问数:  259
  • HTML全文浏览量:  126
  • PDF下载量:  23
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-09-16
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2021-01-19

目录

    /

    返回文章
    返回